<!DOCTYPE html>
<html>
<head>
  <!-- Site made with Mobirise Website Builder v3.11.1, https://mobirise.com -->
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Mobirise v3.11.1, mobirise.com">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="shortcut icon" href="assets/images/logo.png" type="image/x-icon">
  <meta name="description" content="Website Builder Description">
  <title>Website Builder Title</title>
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lora:400,700,400italic,700italic&amp;subset=latin">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Raleway:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i">
  <link rel="stylesheet" href="assets/bootstrap-material-design-font/css/material.css">
  <link rel="stylesheet" href="assets/tether/tether.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="assets/soundcloud-plugin/style.css">
  <link rel="stylesheet" href="assets/dropdown/css/style.css">
  <link rel="stylesheet" href="assets/animate.css/animate.min.css">
  <link rel="stylesheet" href="assets/theme/css/style.css">
  <link rel="stylesheet" href="assets/mobirise/css/mbr-additional.css" type="text/css">
  
  
  
</head>
<body>
<section id="menu-3g">

    <nav class="navbar navbar-dropdown bg-color transparent">
        <div class="container">

            <div class="mbr-table">
                
                <div class="mbr-table-cell">

                    <button class="navbar-toggler pull-xs-right hidden-md-up" type="button" data-toggle="collapse" data-target="#exCollapsingNavbar">
                        <div class="hamburger-icon"></div>
                    </button>

                    <ul class="nav-dropdown collapse pull-xs-right nav navbar-nav navbar-toggleable-sm" id="exCollapsingNavbar"><li class="nav-item"><a class="nav-link link" href="index.html">HOME&nbsp;</a></li><li class="nav-item"><a class="nav-link link" href="Introduction.html">OVERVIEW&nbsp;</a></li><li class="nav-item"><a class="nav-link link" href="Programme.html">PROGRAMME&nbsp;</a></li></ul>
                    <button hidden="" class="navbar-toggler navbar-close" type="button" data-toggle="collapse" data-target="#exCollapsingNavbar">
                        <div class="close-icon"></div>
                    </button>

                </div>
            </div>

        </div>
    </nav>

</section>

<section class="engine"><a rel="external" href="https://mobirise.com">mobirise.com</a></section><section class="mbr-section article mbr-section__container mbr-after-navbar" id="content1-3h" style="background-color: rgb(255, 255, 255); padding-top: 120px; padding-bottom: 0px;">

    <div class="container">
        <div class="row">
            <div class="col-xs-12 lead"><p><strong>Implication of Nrf2/heme oxygenase-1 pathway in articular and skin diseases</strong></p><p><br></p><p>M Carmen Montesinos y M Luisa Ferrándiz</p><p><br></p><p>Department of Pharmacology, Pharmacy School, University of Valencia, Spain</p><p><strong>Email: </strong>monmez@uv.es, luisa.ferrandiz@uv.es</p><p><strong><br></strong></p><p>Autoimmune and chronic inflammatory diseases have a high prevalence and a negative impact on the quality of life of patients. Activation of the transcription factor Nrf2 results in the synthesis of heme oxygenase-1 (HO-1), leading to the formation of bioactive metabolites. We have demonstrated that Nrf2 and HO-1 can confer protection against oxidative stress and inflammatory responses in joint tissues. Thus, Nrf2 deficiency accelerated the incidence of arthritis, and animals showed a widespread disease, using the transfer of serum from arthritic K/BxN transgenic mice to Nrf2−/− mice. In addition, ovariectomized Nrf2−/− mice exhibit a loss in bone mineral density, accompanied by increased osteoblastic and osteoclastic markers, indicating that this transcription factor is indispensable for normal bone microarchitecture. Since HO-1 has shown anti-inflammatory effects in different systems, we investigated its influence on the acute inflammatory response to zymosan in the air pouch model in mice with myeloid-restricted deletion of HO-1 (HO-1M-KO), as well as on different models of arthritis (adjuvant-induced in rats, and collagen-induced or K/BxN serum transfer in mice) with various strategies: therapeutic administration of HO-1 inducers or inhibitors; and used of genetic modified mice (HO-1+/+, HO-1+/− and HO-1−/−). We have currently established different in vitro and in vivo protocols to study chronic inflammatory skin conditions, such as psoriasis, in which Nrf2 has shown to be protective. Further studies are necessary to identify improved strategies to regulate Nrf2 and HO-1 activation in order to enable the development of drugs with therapeutic applications in joint and skin diseases.</p><p><br></p></div>
        </div>
    </div>

</section>

<section class="mbr-section" id="msg-box5-3i" style="background-color: rgb(255, 255, 255); padding-top: 0px; padding-bottom: 0px;">

    
    <div class="container">
        <div class="row">
            <div class="mbr-table-md-up">

              <div class="mbr-table-cell mbr-right-padding-md-up mbr-valign-top col-md-7 image-size" style="width: 37%;">
                  <div class="mbr-figure"><img src="assets/images/montesinos-y-ferrandiz-1400x1015.jpg"></div>
              </div>

              


              <div class="mbr-table-cell col-md-5 text-xs-center text-md-left content-size">
                  
                  <div class="lead">

                    <p><strong>Mª Luisa Ferrándiz Manglano</strong> is full professor of Pharmacology at the University of Valencia. Her main lines of research include: anti-inflammatory and immunomodulatory activity of new compounds of natural and synthetic origin; experimental models of acute and chronic inflammation; implication of the Nrf2/heme oxygenase-1 pathway in the development and resolution of chronic inflammatory processes. In recent years, her research focuses on the development of animal models of arthritis and experimental osteoarthritis, studying the mechanisms involved in these chronic joint pathologies and evaluating new targets and therapeutic strategies. <br><br><strong>Mª Carmen Montesinos</strong> is tenured professor of Pharmacology at the University of Valencia. Her main lines of research are related to the physiological effects of the activation of adenosine receptors and their involvement in promotion of wound healing and in the anti-inflammatory effect of anti-rheumatic drugs. Currently, her research focuses on the study of the pathological processes involved in inflammatory skin diseases in order to improve current therapeutic options.&nbsp;<br></p>

                  </div>

                  
              </div>


              

            </div>
        </div>
    </div>

</section>


  <script src="assets/web/assets/jquery/jquery.min.js"></script>
  <script src="assets/tether/tether.min.js"></script>
  <script src="assets/bootstrap/js/bootstrap.min.js"></script>
  <script src="assets/smooth-scroll/SmoothScroll.js"></script>
  <script src="assets/dropdown/js/script.min.js"></script>
  <script src="assets/touchSwipe/jquery.touchSwipe.min.js"></script>
  <script src="assets/viewportChecker/jquery.viewportchecker.js"></script>
  <script src="assets/theme/js/script.js"></script>
  
  
  <input name="animation" type="hidden">
  </body>
</html>